Phase 2 Encephalitis Clinical Trials
11 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–11 of 11 trials
Recruiting
Phase 1Phase 2
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
Japanese Encephalitis Virus Disease
SK Bioscience Co., Ltd.402 enrolled3 locationsNCT06680128
Recruiting
Phase 2
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Merkel Cell CarcinomaMalignant NeoplasmAcquired Immunodeficiency Syndrome+5 more
M.D. Anderson Cancer Center100 enrolled1 locationNCT02479698
Recruiting
Phase 1Phase 2
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
HealthyHIV Associated Neurocognitive DisorderHIV Dementia+1 more
Yale University70 enrolled1 locationNCT05586581
Recruiting
Phase 2
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis
Autoimmune Encephalitis
Jena University Hospital50 enrolled17 locationsNCT03993262
Recruiting
Phase 2
Adjunctive Doxycycline for Central Nervous System Tuberculosis
Tuberculosis, MeningealTuberculosis; Meningitis (Etiology)Tuberculosis, Central Nervous System+1 more
National University Hospital, Singapore200 enrolled5 locationsNCT06446245
Recruiting
Phase 2
Understanding immune responses to the Yellow Fever (YF) and Japanese Encephalitis (JE) flavivirus vaccines (The FLAVIFLAV Study)
Japanese EncephalitisYellow Fever
The University of Melbourne88 enrolled1 locationACTRN12625000742471
Recruiting
Phase 2
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
EncephalitisAutoimmune Encephalitis
University of Utah116 enrolled39 locationsNCT04372615
Recruiting
Phase 2
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
Autoimmune EncephalitisPsychosis
University of Cambridge70 enrolled10 locationsNCT03194815
Recruiting
Phase 2
Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Beijing Tongren Hospital10 enrolled1 locationNCT06510283
Recruiting
Phase 2
Early Interferon-beta Treatment for West-Nile Virus Infection
West Nile VirusWest Nile Fever EncephalitisWest Nile Fever Myelitis+1 more
Tel-Aviv Sourasky Medical Center100 enrolled1 locationNCT06510426
Recruiting
Phase 2
Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis
Anti-NMDAR Encephalitis
Assistance Publique - Hôpitaux de Paris20 enrolled1 locationNCT03274375